Expression and purification of cGMP grade NY-ESO-1 for clinical trials. (Q54367170)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2011

Language	Label	Description	Also known as
English	Expression and purification of cGMP grade NY-ESO-1 for clinical trials.	scientific article published in March 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

Expression and purification of cGMP grade NY-ESO-1 for clinical trials. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

7

object named as

Gerd Ritter

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

8

object named as

Lloyd J Old

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

Leonardo H S Damasceno

5

object named as

Leonardo M Damasceno

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

9

object named as

Carl A Batt

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

1

object named as

Adam J Lowe

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

Cameron L Bardliving

2

object named as

Cameron L Bardliving

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

author name string

Chung-Jr Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

Leonardo M Teixeira

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

Kyle A Anderson

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

Biotechnology Progress

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

27

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

435-441

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Cancer/testis antigens, gametogenesis and cancer

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

NY-ESO-1 immunotherapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Cancer/testis (CT) antigens: potential targets for immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Expression and purification of the cancer antigen SSX2: a potential cancer vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

The structure of a LysM domain from E. coli membrane-bound lytic murein transglycosylase D (MltD)

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Bcl-XL as a fusion protein for the high-level expression of membrane-associated proteins

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Purification, crystallization and preliminary diffraction studies of AcrB, an inner-membrane multi-drug efflux protein

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

High cell density fed-batch cultivation of Escherichia coli using exponential feeding combined with pH-stat

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Factors affecting endotoxin removal from recombinant therapeutic proteins by anion exchange chromatography

1 reference

https://api.crossref.org/works/10.1002%2FBTPR.552

21 January 2018

Identifiers

10.1002/BTPR.552

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21365782

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54367170&oldid=1743124159"